Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PTI

Proteostasis Therapeutics (PTI) Stock Price, News & Analysis

Proteostasis Therapeutics logo

About Proteostasis Therapeutics Stock (NASDAQ:PTI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.00
$22.42
52-Week Range
N/A
Volume
9,405 shs
Average Volume
1.04 million shs
Market Capitalization
$37.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteostasis Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PTI Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
See More Headlines

PTI Stock Analysis - Frequently Asked Questions

Proteostasis Therapeutics, Inc. (NASDAQ:PTI) posted its earnings results on Monday, November, 16th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.17) by $0.01.

Proteostasis Therapeutics (PTI) raised $51 million in an IPO on Thursday, February 11th 2016. The company issued 3,900,000 shares at $12.00-$14.00 per share. Leerink Partners and RBC Capital Markets served as the underwriters for the IPO and Baird and H.C. Wainwright & Co. were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Proteostasis Therapeutics investors own include BHP Group (BHP), Idera Pharmaceuticals (IDRA), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Bristol Myers Squibb (BMY), Rite Aid (RAD) and

Company Calendar

Last Earnings
11/16/2020
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PTI
CIK
1445283
Fax
N/A
Employees
44
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$59.13 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-75.39%
Return on Assets
-55.04%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.69
Quick Ratio
6.69

Sales & Book Value

Annual Sales
$5 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.22 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
52,185,000
Free Float
N/A
Market Cap
$37.57 million
Optionable
Not Optionable
Beta
1.16
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:PTI) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners